Affiliation:
1. Stavropol State Medical University
Abstract
Diabetes mellitus (DM) is one of severe and progressive endocrine system diseases that occur in childhood. Type 1 DM, the form most commonly seen in children and adolescents, develops as an autoimmune process that gradually inflicts damage and causes death of pancreatic β cells. During its course MD gives rise to a number of severe complications, the most significant of which is the dysfunction and damage of the central nervous system (CNS). The leading causes of CNS damage in DM can be subdivided into vascular, metabolic, neurodegenerative and inflammatory. The main clinical presentation of DM in pediatric practice is cognitive impairment, characterized by a decline in memory and intellectual function. Despite the success that have been achieved in the MD treatment field, prevention and detection of CNS function impairment occurring in this disease remains an important direction for research in the endocrine practice, especially when treating children and adolescents.
Subject
Process Chemistry and Technology,Economic Geology,Fuel Technology
Reference34 articles.
1. Arroyave F., Montaсo D., Lizcano F. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells. 2020;21(22):8685. doi: 10.3390/ijms21228685., Arroyave F., Montaso D., Lizcano F. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells. 2020;21(22):8685. doi: 10.3390/ijms21228685.
2. Avilйs-Santa M.L., Monroig-Rivera A., Soto- Soto A., Lindberg N.M. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across theContinent.CurrDiab Rep. 2020;20(11):62. doi:10.1007/ s11892-020-01341-9., Avilys-Santa M.L., Monroig-Rivera A., Soto- Soto A., Lindberg N.M. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across theContinent.CurrDiab Rep. 2020;20(11):62. doi:10.1007/ s11892-020-01341-9.
3. Zhao R., Lu Z., Yang J., Zhang L., Li Y., Zhang X. Drug Delivery System in the Treatment of Diabetes Mellitus. Front BioengBiotechnol. 2020;8:880. doi: 10.3389/fbioe.2020.00880., Zhao R., Lu Z., Yang J., Zhang L., Li Y., Zhang X. Drug Delivery System in the Treatment of Diabetes Mellitus. Front BioengBiotechnol. 2020;8:880. doi: 10.3389/fbioe.2020.00880.
4. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., Shaw JE, Bright D., Williams R. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843, Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., Shaw JE, Bright D., Williams R. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
5. Infante-Garcia C., Garcia-Alloza M. Review of the Effect of Natural Compounds and Extracts on Neurodegeneration in Animal Models of Diabetes Mellitus. Int J Mol Sci. 2019;20(10):2533. doi:10.3390/ ijms20102533., Infante-Garcia C., Garcia-Alloza M. Review of the Effect of Natural Compounds and Extracts on Neurodegeneration in Animal Models of Diabetes Mellitus. Int J Mol Sci. 2019;20(10):2533. doi:10.3390/ ijms20102533.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献